All In Biotech

Drug Trial Radar · NCT02539134

TAK-935 Multiple Rising Dose Study in Healthy Participants

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Multiple Doses of TAK-935 in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Sep 2015

Primary completion

Apr 2016

Study completion Apr 2016

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Sep 2, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of multiple rising doses of TAK-935 in healthy participants.

Conditions

  • Epilepsy

Interventions

  • TAK-935Drug

    TAK-935 oral solution

  • PlaceboDrug

    TAK-935 placebo-matching oral solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Experience at Least One Treatment-emergent Adverse Event (TEAE)Time frame: Day 1 up to Day 28
  2. Percentage of Participants Who Meet the Takeda Markedly Abnormal Criteria for Safety Laboratory Tests at Least Once Post DoseTime frame: Baseline up to Day 15
  3. Percentage of Participants Who Meet the Takeda Markedly Abnormal Criteria for Vital Sign Measurements at Least Once Post DoseTime frame: Baseline up to Day 15
  4. Percentage of Participants Who Meet the Takeda Markedly Abnormal Criteria for Safety 12-lead Electrocardiogram (ECG) Parameters at Least Once Post DoseTime frame: Baseline up to Day 15

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Austin, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.